Unicycive Therapeutics (UNCY) Treasury Shares (2021 - 2026)

Unicycive Therapeutics (UNCY) has 6 years of Treasury Shares data on file, last reported at $478419.0 in Q1 2026.

• Quarterly Treasury Shares fell 90.0% year-over-year to $478419.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $478419.0 (down 90.0% YoY) and the FY2025 annual result came in at $478419.0, changed 0.0% from the prior year.
• Treasury Shares held at $478419.0 in Q1 2026, from $478419.0 in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $11.9 million in Q2 2023 to a low of $352938.0 in Q1 2023.
• A 5-year average of $3.4 million and a median of $1.6 million in 2023 frame the typical range for Treasury Shares.
• Annual changes were most pronounced in 2024 — Treasury Shares surged 1255.53% — and 2025, when it sank 94.04%.
• Tracing UNCY's Treasury Shares over 5 years: stood at $389676.0 in 2022, then jumped by 1127.74% to $4.8 million in 2023, then sank by 90.0% to $478419.0 in 2024, then changed by 0.0% to $478419.0 in 2025, then changed by 0.0% to $478419.0 in 2026.
• The last three Treasury Shares figures came in at $478419.0 (Q1 2026), $478419.0 (Q4 2025), and $478419.0 (Q3 2025), per Business Quant data.